Ask a new question


ME/CFSCerebral PalsyParkinson'sLong CovidMultiple SclerosisMCASCystic FibrosisStrokeEpilepsyEndometriosisMigraineALSLupus
TreatmentsLists
Most popular ways to manage stiffness, pain, and rigidity in Parkinson'sBest treatments to boost energy and motivation in Parkinson's10 non-medication based treatments for Parkinson's
Download community app

Ask a new question


ME/CFSCerebral PalsyParkinson'sLong CovidMultiple SclerosisMCASCystic FibrosisStrokeEpilepsyEndometriosisMigraineALSLupus
TreatmentsLists
Most popular ways to manage stiffness, pain, and rigidity in Parkinson'sBest treatments to boost energy and motivation in Parkinson's10 non-medication based treatments for Parkinson's
Download community app
Parkinsons/Q&A/What Part Of Brain Affected

What part of the brain is most affected by Parkinson's disease?

4 Patient views
5 Expert views
9 Resources

The basics

Parkinson's disease primarily affects a specific area of the brain known as the substantia nigra. This region is located in the midbrain and plays a crucial role in movement control.

Substantia Nigra

  • Function: The substantia nigra is part of the basal ganglia, a group of structures linked to the control of voluntary motor movements, procedural learning, and routine behaviors or "habits."
  • Dopamine Production: It is responsible for producing dopamine, a neurotransmitter essential for coordinating smooth and balanced muscle movements.

Impact of Parkinson's Disease

  • Dopamine Deficiency: In Parkinson's disease, the neurons in the substantia nigra gradually degenerate and die, leading to a significant reduction in dopamine levels. This deficiency is what causes the hallmark symptoms of Parkinson's, such as tremors, stiffness, and bradykinesia (slowness of movement).
  • Progressive Nature: The disease is progressive, meaning that the damage to the substantia nigra and the resulting symptoms worsen over time.

Other Affected Areas

While the substantia nigra is the most affected, Parkinson's disease can also impact other parts of the brain and nervous system:

  • Basal Ganglia: Other components of the basal ganglia are also affected, contributing to the motor symptoms.
  • Cortex: As the disease progresses, it can affect the cerebral cortex, leading to cognitive and behavioral changes.
  • Autonomic Nervous System: Non-motor symptoms, such as changes in blood pressure regulation, can occur due to the involvement of the autonomic nervous system.

Understanding the specific areas of the brain affected by Parkinson's disease helps in developing targeted treatments and therapies to manage symptoms and improve quality of life for those affected.


What patients say

4 Patient views

In discussions about Parkinson's disease, patients and community members often focus on the role of the substantia nigra, a part of the brain significantly affected by the disease.

Positive Insights

  • Some users express interest in ongoing research aimed at understanding why dopamine neurons in the substantia nigra are particularly vulnerable and how they might be protected or restored3.

Concerns and Questions

  • A user humorously described the brain's need for dopamine, highlighting the critical role of dopamine in managing Parkinson's symptoms1.
  • There are inquiries about the correlation between lifestyle habits and the loss of neurons in the substantia nigra, indicating a concern for prevention and understanding the disease's progression4.

Educational Content

  • An educational video from Parkinson’s UK explains that Parkinson’s disease develops in the substantia nigra when dopamine-producing cells die, leading to movement issues. This video is part of efforts to educate the public about the disease's mechanisms and potential treatments2.

Patient View

Parkinson’s is Your brain on the street corner holding a sign that says “will work for dopamine”

October 2024 • Turnto Crowd Question

Patient View

In this educational video from Parkinson’s UK, we find out more about Parkinson’s disease. The film explains that Parkinson’s disease develops in the substantia nigra part of the brain when the cells begin to die. These cells produce dopamine and the loss of dopamine in the brain leads to issues with movement. As the disease progresses and the brain has less and less dopamine, the symptoms of the disease become more apparent and the patient develops tremors, difficulty walking, and other issues with movement. Researchers are working on ways to stop or slow down the loss of these dopamine-producing cells so that Parkinson’s disease may be treated and ultimately cured. Click here to watch the video and learn more about this. What did you think about this video? Are you interested in more information on this topic?

June 2024 • Parkinson's News Today


What the experts say

5 Expert views

Parkinson's disease primarily affects a specific part of the brain known as the substantia nigra. This area is located in the midbrain and is crucial for the production of dopamine, a neurotransmitter essential for regulating movement. The degeneration of dopamine-producing neurons in the substantia nigra leads to the characteristic motor symptoms of Parkinson's disease, such as tremors, rigidity, and bradykinesia (slowness of movement)123.

The Role of the Substantia Nigra

  • Dopamine Production: The substantia nigra is responsible for producing dopamine, which is vital for smooth and coordinated muscle movements. As Parkinson's progresses, the loss of dopamine in this area results in impaired movement control14.
  • Impact on Movement: The substantia nigra sends dopamine to other parts of the brain, such as the putamen and caudate, which are involved in movement regulation. The reduction in dopamine affects these areas, leading to the motor symptoms associated with Parkinson's15.

Broader Implications

  • Cognitive and Emotional Effects: While the primary impact is on movement, the loss of dopamine also affects other brain areas, potentially leading to cognitive and emotional changes. This includes impacts on the basal ganglia, which can influence cognitive functions and mood23.

Understanding the role of the substantia nigra and its connection to other brain regions helps in comprehending the complex nature of Parkinson's disease and its wide-ranging effects on both motor and non-motor functions.

Video

This video explains that Parkinson's disease primarily affects the substantia nigra, a part of the midbrain responsible for dopamine production. The degeneration of dopamine neurons in this area leads to the motor symptoms of Parkinson's. The substantia nigra sends dopamine to the putamen and caudate, crucial for movement control.

March 2021 • Cure Parkinson's

Video

This video discusses how decreased dopamine production in Parkinson's disease affects the basal ganglia, a brain area crucial for movement control. The basal ganglia's impairment leads to motor symptoms and can also affect cognitive functions, highlighting the broad impact of dopamine loss in Parkinson's.

December 2020 • Parkinson’s Disease Education


Related resources

9 Resources
Discusses DaTscan brain imaging in diagnosing Parkinson's, focusing on the substantia nigra.

Discusses DaTscan brain imaging in diagnosing Parkinson's, focusing on the substantia nigra.

January 2024 • The Michael J. Fox Foundation Parkinson's Podcast

Explores noradrenergic system's role in Parkinson's, linked to the locus coeruleus.

Explores noradrenergic system's role in Parkinson's, linked to the locus coeruleus.

April 2024 • The Brain Podcast

Discusses therapies for Parkinson's by addressing neural synchronicity.

Discusses therapies for Parkinson's by addressing neural synchronicity.

September 2022 • The Future of Everything

Explains brain areas affected by Parkinson's, focusing on the substantia nigra.

Explains brain areas affected by Parkinson's, focusing on the substantia nigra.

March 2024 • Parkinson's UK

Details how Parkinson's affects the substantia nigra and other brain areas.

Details how Parkinson's affects the substantia nigra and other brain areas.

February 2023 • Healthline

Overview of Parkinson's, focusing on substantia nigra's role in symptoms.

Overview of Parkinson's, focusing on substantia nigra's role in symptoms.

April 2024 • American Association of Neurological Surgeons (AANS)

Explains causes of Parkinson's, focusing on substantia nigra and dopamine.

Explains causes of Parkinson's, focusing on substantia nigra and dopamine.

November 2022 • NHS

Discusses Parkinson's impact on brain, focusing on basal ganglia.

Discusses Parkinson's impact on brain, focusing on basal ganglia.

Johns Hopkins Medicine

Explores cognitive changes in Parkinson's, focusing on basal ganglia.

Explores cognitive changes in Parkinson's, focusing on basal ganglia.

Parkinson's Foundation

Was this helpful?

This is not healthcare advice or a recommendation. This tool is in beta and currently experimental. It is designed to help you find the most recent and helpful sources, from different voices, for you to take to consider with your healthcare team.

We appreciate any feedback as we aim to help speed up breakthroughs for all conditions.


Related questions
How does Parkinson's disease affect the brain?
What are the symptoms of Parkinson's disease?
How is Parkinson's disease diagnosed?
What treatments are available for Parkinson's disease?
Can lifestyle changes help manage Parkinson's disease?

Explore more lists

More lists
Most popular ways to manage stiffness, pain, and rigidity in Parkinson's
Community list

Most popular ways to manage stiffness, pain, and rigidity in Parkinson's

229 experts
327 patients

Curated by Crowd
Verified by Turnto
Best treatments to boost energy and motivation in Parkinson's
Community list

Best treatments to boost energy and motivation in Parkinson's

217 experts
273 patients

Curated by Crowd
Verified by Turnto
More lists
Turn on alertsNext in 0m
Get everything related to you in one easy update.

TermsPrivacyDisclaimerContact

© 2026 Turnto

Stay up to date on ParkinsonsGet everything Parkinsons symptoms related to you in one easy update.Try for free
Turny found you 16 things (Physiotherapy, New medications)
Turny (with Turnto) 2 mins ago
to me